A Safety and Efficacy Study Evaluating CTX130 in Subjects With Relapsed or Refractory T or B Cell Malignancies (COBALT-LYM)
CRISPR Therapeutics
CRISPR Therapeutics
Pfizer
The First Affiliated Hospital with Nanjing Medical University
Beijing Boren Hospital
Agios Pharmaceuticals, Inc.
Fred Hutchinson Cancer Center
Yale University
Case Comprehensive Cancer Center
Nevada Cancer Institute